The prostate contracts and forces these fluids out during orgasm. The protein excreted by prostate cancer treatment metastatic the prostate, prostate-specific antigen (PSA), helps semen retain its liquid state.
An excess of this protein prostate cancer treatment metastatic in the blood is one of the first signs of prostate cancer. The urethra is tube through which sperm and urine exit the body. As such, the prostate prostate cancer treatment metastatic is also responsible for urine control.
It can tighten and restrict Prostate cancer treatment metastatic the flow of urine through Prostate cancer treatment metastatic the urethra using thousands of tiny muscle fibers.
Tiny changes occur in the shape and size of the prostate gland cells, known as prostatic Intraepithelial neoplasia (PIN). This tends to happen slowly and prostate cancer treatment metastatic does not show symptoms until further Prostate cancer treatment metastatic into the progression. Nearly 50 prostate cancer treatment metastatic percent of all men over the age of 50 years have PIN.
High-grade PIN is considered pre-cancerous, and it requires further investigation. Prostate cancer can be successfully treated if it is diagnosed before metastasis, but if it spreads, it is more dangerous.
Stages Staging takes into account the size and extent of the tumor and the scale of the metastasis (whether prostate cancer treatment metastatic it has traveled to other Prostate cancer treatment metastatic organs and tissues).
At Stage 0, the tumor has neither spread from the prostate gland nor invaded Deeply into it.
At Stage 4, the cancer has spread to distant sites and organs.
Diagnosis prostate cancer treatment metastatic A doctor will carry out a physical examination and enquire about any ongoing medical history. If the patient has symptoms, or if a routine blood test shows abnormally Prostate cancer treatment metastatic high PSA levels, further examinations may be requested.
Imaging scans can show and track the presence of prostate cancer. Imaging scans can show and track the presence of prostate cancer.
Tests may include: prostate cancer treatment metastatic a digital rectal examination (DRE), in which a doctor will manually check for any abnormalities of the prostate with their finger a biomarker test checking the blood, urine, or body tissues of a person with cancer for chemicals unique to individuals with cancer If these tests show abnormal results, further tests will include: a PCA3 test examining the urine for the Prostate cancer treatment metastatic PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of the affected region using a probe that emits sounds a biopsy, or the removal of 12 to 14 small pieces of tissue from several areas of the prostate for prostate cancer treatment metastatic examination under a microscope These prostate cancer treatment metastatic will help confirm the stage of the cancer, whether it has spread, and what treatment is appropriate. To Prostate cancer treatment metastatic track any spread, or metastasis, doctors may use a bone, Prostate cancer treatment metastatic CT scan, or MRI scan. Outlook If the disease is found before it spreads to other organs in a process known as metastasis, the 5-year Survival rate is 99 percent. Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it is still treatable.
Risk factors The exact cause prostate cancer treatment metastatic of prostate cancer is unclear, but there are many possible risk Prostate cancer treatment metastatic factors. Age Prostate cancer is rare prostate cancer treatment metastatic among men under the age of 45 years, but more common prostate cancer treatment metastatic after the age of 50 years.
Adenoma mass
Enlarged prostate treatment 2017
Adenoma cells
V. s. adenoma
Pi rads 5 prostate cancer treatment
| 12.07.2017 - FB_GS_BJK_TURKIYE |
| Percent more common and 2 to 3 times more. |
| 12.07.2017 - Hayatim |
| Vegetables can improve your obesity decreases the risk that. |
| 12.07.2017 - Gozel |
| PAGE: You will find out more about prostate gland for examination the original boosters. |
| 12.07.2017 - Alla |
| And urinary problems that result outweighs the need for that. |
| 12.07.2017 - VERSACE |
| Only a very small testing a Valid Risk Indicator doctor as part of your yearly physical examination. Age. |
No comments:
Post a Comment